46 related articles for article (PubMed ID: 38438882)
21. The DOCK protein family in vascular development and disease.
Benson CE; Southgate L
Angiogenesis; 2021 Aug; 24(3):417-433. PubMed ID: 33548004
[TBL] [Abstract][Full Text] [Related]
22. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
23. Ezrin Mediates Invasion and Metastasis in Tumorigenesis: A Review.
Song Y; Ma X; Zhang M; Wang M; Wang G; Ye Y; Xia W
Front Cell Dev Biol; 2020; 8():588801. PubMed ID: 33240887
[TBL] [Abstract][Full Text] [Related]
24. Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview.
Mondal S; Adhikari N; Banerjee S; Amin SA; Jha T
Eur J Med Chem; 2020 May; 194():112260. PubMed ID: 32224379
[TBL] [Abstract][Full Text] [Related]
25. Molecular characterization of endometrial cancer and therapeutic implications.
Winterhoff B; Thomaier L; Mullany S; Powell MA
Curr Opin Obstet Gynecol; 2020 Feb; 32(1):76-83. PubMed ID: 31851045
[TBL] [Abstract][Full Text] [Related]
26. DOCK1 Regulates Growth and Motility through the RRP1B-Claudin-1 Pathway in Claudin-Low Breast Cancer Cells.
Chiang SK; Chang WC; Chen SE; Chang LC
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31717460
[TBL] [Abstract][Full Text] [Related]
27. RAF kinases are stabilized and required for dendritic cell differentiation and function.
Riegel K; Schlöder J; Sobczak M; Jonuleit H; Thiede B; Schild H; Rajalingam K
Cell Death Differ; 2020 Apr; 27(4):1300-1315. PubMed ID: 31541179
[TBL] [Abstract][Full Text] [Related]
28. Clinical actionability of molecular targets in endometrial cancer.
Urick ME; Bell DW
Nat Rev Cancer; 2019 Sep; 19(9):510-521. PubMed ID: 31388127
[TBL] [Abstract][Full Text] [Related]
29. Nuclear ERK: Mechanism of Translocation, Substrates, and Role in Cancer.
Maik-Rachline G; Hacohen-Lev-Ran A; Seger R
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30857244
[TBL] [Abstract][Full Text] [Related]
30. Mutations in dock1 disrupt early Schwann cell development.
Cunningham RL; Herbert AL; Harty BL; Ackerman SD; Monk KR
Neural Dev; 2018 Aug; 13(1):17. PubMed ID: 30089513
[TBL] [Abstract][Full Text] [Related]
31. Silencing of dedicator of cytokinesis (DOCK180) obliterates pregnancy by interfering with decidualization due to blockage of nuclear entry of autoimmune regulator (AIRE).
Mohan JJ; Narayan P; Padmanabhan RA; Joseph S; Kumar PG; Laloraya M
Am J Reprod Immunol; 2018 Jul; 80(1):e12844. PubMed ID: 29516628
[TBL] [Abstract][Full Text] [Related]
32. EGFR Signals through a DOCK180-MLK3 Axis to Drive Glioblastoma Cell Invasion.
Misek SA; Chen J; Schroeder L; Rattanasinchai C; Sample A; Sarkaria JN; Gallo KA
Mol Cancer Res; 2017 Aug; 15(8):1085-1095. PubMed ID: 28487380
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of DOCK1 sensitizes bladder cancer cells to cisplatin through preventing epithelial-mesenchymal transition.
Chen DJ; Chen W; Jiang H; Yang H; Wang YC; Chen JH
Drug Des Devel Ther; 2016; 10():2845-2853. PubMed ID: 27660415
[TBL] [Abstract][Full Text] [Related]
34. Dock1 promotes the mesenchymal transition of glioma and is modulated by MiR-31.
Zhang B; Li H; Yin C; Sun X; Zheng S; Zhang C; Shi L; Liu Y; Lu S
Neuropathol Appl Neurobiol; 2017 Aug; 43(5):419-432. PubMed ID: 26946516
[TBL] [Abstract][Full Text] [Related]
35. Protein kinase A-dependent phosphorylation of Dock180 at serine residue 1250 is important for glioma growth and invasion stimulated by platelet derived-growth factor receptor α.
Feng H; Li Y; Yin Y; Zhang W; Hou Y; Zhang L; Li Z; Xie B; Gao WQ; Sarkaria JN; Raizer JJ; James CD; Parsa AT; Hu B; Cheng SY
Neuro Oncol; 2015 Jun; 17(6):832-42. PubMed ID: 25468898
[TBL] [Abstract][Full Text] [Related]
36. Impaired cell death and mammary gland involution in the absence of Dock1 and Rac1 signaling.
Bagci H; Laurin M; Huber J; Muller WJ; Côté JF
Cell Death Dis; 2014 Aug; 5(8):e1375. PubMed ID: 25118935
[TBL] [Abstract][Full Text] [Related]
37. Elmo1 helps dock180 to regulate Rac1 activity and cell migration of ovarian cancer.
Wang J; Dai JM; Che YL; Gao YM; Peng HJ; Liu B; Wang H; Linghu H
Int J Gynecol Cancer; 2014 Jun; 24(5):844-50. PubMed ID: 24819662
[TBL] [Abstract][Full Text] [Related]
38. PI3K regulates MEK/ERK signaling in breast cancer via the Rac-GEF, P-Rex1.
Ebi H; Costa C; Faber AC; Nishtala M; Kotani H; Juric D; Della Pelle P; Song Y; Yano S; Mino-Kenudson M; Benes CH; Engelman JA
Proc Natl Acad Sci U S A; 2013 Dec; 110(52):21124-9. PubMed ID: 24327733
[TBL] [Abstract][Full Text] [Related]
39. p130Cas: a key signalling node in health and disease.
Barrett A; Pellet-Many C; Zachary IC; Evans IM; Frankel P
Cell Signal; 2013 Apr; 25(4):766-77. PubMed ID: 23277200
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of dedicator of cytokinesis I (Dock180) in ovarian cancer correlated with aggressive phenotype and poor patient survival.
Zhao F; Siu MK; Jiang L; Tam KF; Ngan HY; Le XF; Wong OG; Wong ES; Chan HY; Cheung AN
Histopathology; 2011 Dec; 59(6):1163-72. PubMed ID: 22175896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
